SHEA GUIDELINES Bundle (free trial)

C diff

SHEA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1524017

Contents of this Issue

Navigation

Page 6 of 15

7 S, strong ; W, weak; C, conditional; H, high; M, moderate; L, low; VL, very low quality of evidence; GP, good practice; NR, no recommendation ➤ Terminal room cleaning with a sporicidal agent should be considered in conjunction with other measures to prevent CDI during endemic high rates or outbreaks or if there is evidence of repeated cases of CDI in the same room (W-L). ➤ Incorporate measures of cleaning effectiveness to ensure quality of environmental cleaning (GP). ➤ There are limited data at this time to recommend use of automated, terminal disinfection using a sporicidal method for CDI prevention (NR). ➤ Daily cleaning with a sporicidal agent should be considered in conjunction with other measures to prevent CDI during outbreaks or in hyperendemic (sustained high rates) settings, or if there is evidence of repeated cases of CDI in the same room (W-L). ➤ There are insufficient data to recommend screening for asymptomatic carriage and placing asymptomatic carriers on contact precautions (NR). ➤ Minimize the frequency and duration of high-risk antibiotic therapy and the number of antibiotic agents prescribed, to reduce CDI risk (S-M). ➤ Implement an antibiotic stewardship program (GP). ➤ Antibiotics to be targeted should be based on the local epidemiology and the C. difficile strains present. Restriction of fluoroquinolones, clindamycin and cephalosporins (except for surgical antibiotic prophylaxis) should be considered (S-M). ➤ Although there is an epidemiologic association between proton pump inhibitors (PPIs) use and CDI, and unnecessary PPIs should always be discontinued, there is insufficient evidence for discontinuation of PPIs as a measure for preventing CDI (NR). ➤ There are insufficient data at this time to recommend administration of probiotics for primary prevention of CDI outside of clinical trials (NR).

Articles in this issue

Archives of this issue

view archives of SHEA GUIDELINES Bundle (free trial) - C diff